• Publications
    Expected Returns Articles
  • Research
    Companies Funds Top 40 My Studies
  • Stock Screen
    New Stock Screen Manage Screens
  • Dashboards
    My Dashboards New Dashboard
  • Forum
  • Events
  • Search
  • Contact Us
  • Sign In

Jazz Pharmaceuticals (JAZZ)

Company Ticker Sector | Industry Quality PAR
Jazz Pharmaceuticals JAZZ Healthcare | Biotechnology 48 20.3%
Current Price ( 5/22 4:00PM EDT) $107.82
Projected Return on Value (PROVE) 22.0%
Relative Momentum 89.9
Expected Income Statement
Current Sales 4,069.0
Sales Growth Forecast 6.2%
Net Profit Margin 28.1%
Projected Shares Outstanding 60.00
EPS - Five year Forecast $25.74
Average P/E Ratio 10.6
Projected Average Price $272.11
Price Appreciation (Annualized) 20.3%
Annual Dividend Yield 0.0%
Projected Annual Return 20.3%
Quality
Financial Strength 47 11.7
EPS Stability 62 15.5
Industry Sales Growth Rate 15.0% 5.2
Industry Net Profit Margin 30.0% 11.7
Calculated Quality Rating 44.0
Fundamental Data Updated: 02/28/2025
MIPAR 9.9%  
Sweet Spot 14.9% - 19.9%  
Top In Biotechnology
Ticker Quality PAR
UTHR 94 19.0%
GMAB 75 19.6%
HALO 77 21.2%
REGN 84 13.6%
SIGA 55 18.8%
Top In Healthcare
Ticker Quality PAR
UTHR 94 19.0%
UNH 96 22.9%
LNTH 80 20.2%
MOH 81 21.4%
GMAB 75 19.6%

© 2006 - 2025 Manifest Investing. All rights reserved.
About | Terms of Service | Disclaimer | Privacy Policy

Legend
Quality Legend:
Blue Excellent with quality greater than 80.
Green Good with quality between 60 and 80.
Neutral Average or below average with quality between 20 and 60.
Red Poor with quality less than 20.
Companies with less than 10 years of history are penalized by 5 points per year.
PAR Legend:
Green PAR is within the target range of MIPAR +5-10%, currently 5.1%-10.1%
Yellow PAR is above the target range of MIPAR +10%, currently 10.1%
PAR Projected Annual Return
MIPAR The Manifest Investing Median PAR of all stocks in the database.
Company Name Legend:
* Not covered by Value Line Standard Edition.
b Uses price-to-book value for valuation purposes.
P/CF Uses price-to-cash flow for valuation.